Page 75 - Traitements à Istanbul (Turquie)

Dr. Ayse Sercin Kulsoy is an obstetrician-gynaecologist and surgeon. She graduated from Istanbul University Faculty of Medicine in 1991. She has over 30 years of experience in women’s health care.

Expertise includes prenatal care; normal and caesarean deliveries; gynaecological surgery for fibroids, ovarian cysts, and endometriosis. She also evaluates and treats infertility and ovulation disorders, and offers assisted reproductive techniques. She manages menopause and provides preventive care, including cervical cancer screening and HPV management. Language: English.

Docteur Asude Koksal a débuté sa carrière en tant que diplômée de la Faculté de médecine de l'Université de Gazi, Département de chirurgie plastique, reconstructive et esthétique. Travaillant dans de nombreux hôpitaux et cliniques différents, le Dr Asude Köksal est une spécialiste expérimentée dans le domaine de la chirurgie plastique. Spécialiste Dr Asude Koksal ; effectue de nombreuses opérations différentes telles que l'abdominoplastie, le remodelage du visage avec des produits de comblement, le lifting des cuisses, le BBL, l'esthétique mammaire, le lifting des bras, la gynécomastie et la liposuccion.

Conditions traitées

• Problèmes d'apparence esthétique

Malformations congénitales

Trouble post-traumatique

Traitement des tumeurs cutanées

Fractures des os du visage

Adhérences congénitales

Plaintes autour des yeux

Méthodes de traitement

Lifting du visage

Reconstruction craniofaciale

Blépharoplastie

Greffe de cheveux

Chirurgie de l'oreille

Rhinoplastie

Esthétique mammaire

Abdominoplastie

Liposuccion

Chirurgie de la hanche

Microchirurgie

Botox

Recherche et publications

• Révision des réductions mammaires selon le modèle Wise avec des procédures verticales (Annals of Plastic Surgery Volume 74, Numéro 3, Mars 2015)
• Fasciite nécrosante due à Streptococcus mitis causée par une morsure humaine accidentelle (JIDC 2016 ; 10(1) : 100-102
• Reconstruction des défauts tissulaires de la main avec lambeau radial inversé de l'avant-bras (Gazi Medical Journal, 2016 ; 27 : 11-14)
• Notre expérience clinique en chirurgie reconstructive des défauts de la paroi thoracique antérieure avec le département de chirurgie thoracique (Gazi Medical Journal, 2015 ; 26 : 222-224)

Certifications

Certificat d'application de charges et de neurotoxines

Certificat d'applications intentionnelles esthétiques et de beauté sur le visage et le corps avec des appareils à base de laser, IPL, radiofréquence et ultrasons

Certificat de mésothérapie, derma roller, d'applications PRP et de soins de la peau

Cours sur les procédures esthétiques non chirurgicales

8e cours européen de chirurgie plastique et esthétique et de rhinoplastie

13e Congrès Européen de Microchirurgie

Symposium sur les interventions esthétiques non chirurgicales et les médias

TPRECD *37e Congrès national sur la réparation mammaire

Cours de chirurgie esthétique du sein au 37e Congrès national du TPRECD

8e cours de rhinoplastie du TPRECD

Cours TPRECD de rhinoplastie ouverte sur cadavre frais

TPRECD 1er cours d'esthétique et de sculpture faciale

Association turque de chirurgie de la main et des membres supérieurs 9e cours de base de chirurgie de la main du professeur Dr. Rıdvan Ege

35e Congrès national du TPRECD

TPRECD : Association turque de chirurgie plastique, reconstructive et esthétique)

Dr. Tugce Gurbuzturk is a Dentist and Orthodontist. She is the founder of Hospitaprime in Istanbul. She focuses on advanced orthodontic treatments, such as orthognathic surgery and Invisalign. Dr. Gurbuzturk is known for achieving high success rates in complex dental cases.

She earned her dental degree from Hacettepe University (2016–2021). She then completed advanced orthodontic training at Okan University. Dr. Gurbuzturk is recognized for her expertise and dedication to evidence-based care. She provides dental services at Hospitaprime and Liv Hospital.

Areas of Interests

• Diagnosis and Treatment of Peripheral Vascular Disease - Endovascular / Hybrid / Surgical Interventions (Percutaneous arterial and venous interventions (atherectomy, pharmacomechanical thrombectomy, selective thrombolytic procedures, stent, balloon), EVAR-TEVAR, Stem Cell
• Diabetic Foot
• Critical Leg Ischemia / Gangrene (Acute or Chronic)
• Deep Vein Thrombosis
• Carotid Artery Stenosis
• aneurysm
• Varicose Veins Treatment (Radiofrequency, surgery, hybrid, sclerotherapy)
• Chronic Renal Failure Vascular Access Problems (Arteriovenous Fistula) (Endovascular – Surgical Interventions)
• Hybrid Vascular Surgery (Interventions in which Open and Angiographic Techniques are used simultaneously)
• Vascular Surgery
• Academic Development
• Adult Heart Surgery (coronary bypass, Valve Surgery)

Education

• Hacettepe University Faculty of Medicine / Undergraduate / 1994-2000
• Hacettepe University / Faculty of Medicine / M.Sc. / 2000
• Turkey Yüksek İhtisas Hospital Clinic of Cardiovascular Surgery / Ph.D.-S. Competency-Medical Specialization / 2007
• University of Health Sciences Ankara  Numune Eah Cardiovascular Surgery / Associate Professor Title / 2018

Experience

• Ataturk Chest Disease. And Sky. Cer. Eah Cardiovascular Surgery Clinic / 2007-2008
• Erzurum Marshal Çakmak Hospital (Military Service) / 2008-2009
• Ataturk Chest Disease. And Sky. Cer. Eah Cardiovascular Surgery Clinic / 2009-2011
• Establishment of Ankara Training and Research Hospital Cardiovascular Surgery Clinic / 2011-2013
• Health Sciences University Ankara Numune Training and Research Hospital / 2013-2019
• Yüksekova State Hospital (Temporary Assignment) / 21.9.2016-12.10.2016
• Derecik Barracks Mobile Field Hospital within the Scope of Operation Claw / 20.6.2019-20.07.2019
• Health Sciences University Ankara City Hospital / 2019-2020
• Baskent University Alanya Practice and Research Hospital / 2020-2022

Le Dr Ceren Çetinbay, diplômée de la Faculté de médecine dentaire de l'Université de Marmara en 2017, a commencé sa formation de spécialisation en tant qu'assistante de recherche au Département d'endodontie de la Faculté de médecine dentaire de l'Université de Marmara en 2018. Elle a terminé sa formation de spécialisation en 2021 et a commencé sa carrière médicale active. Elle est spécialiste en endodontie dans notre clinique sur des questions spécifiques telles que le traitement du canal radiculaire, le traitement du canal radiculaire sous microscope dentaire et l'élimination des corps étrangers du canal dentaire. C'est une dentiste expérimentée qui utilise des matériaux de haute qualité et les dernières technologies pendant et après le traitement.

Français Le Dr Deniz Selin Kahya, diplômée de la Faculté de médecine dentaire de l'Université de Marmara en 2012, a terminé sa formation spécialisée en dentisterie restauratrice à l'hôpital de formation et de recherche Bezmi Alem Valide Sultan Vakıf Gureba en 2016. En raison de son domaine d'expertise, elle s'occupe des obturations esthétiques de la région antérieure, des facettes stratifiées en composite et en céramique et des traitements dentaires qui protègent le tissu dentaire et fournissent des résultats esthétiques.

Le Dr Cenan Oktay est né en 1965 à Plovdiv-Bulgarie. Il a terminé ses études primaires à Istanbul en 1977. Il a terminé ses études secondaires et secondaires au lycée Erkek d'Istanbul, qui dispense un enseignement en allemand. Il est diplômé de la faculté de médecine de l'Université de Trakya en 1984.

En raison de son intérêt pour la chirurgie, il a effectué son stage de chirurgie générale alors qu'il était étudiant, chef des cliniques de chirurgie de l'Université de Heidelberg en Allemagne, Prof.Dr. ch. Il l'a fait avec Herfarth.

Il a obtenu son 3ème diplôme à la Faculté de médecine en 1990 et a commencé sa formation de spécialisation en chirurgie générale à l'hôpital de formation SSK Okmeydanı d'Istanbul en septembre 1991. Il a préparé des publications de congrès ainsi que des études cliniques et expérimentales au cours de sa résidence.

En 1993, il a reçu une formation sur le « Cours de microchirurgie » et les anneaux « Valtrac » utilisés dans les anastomoses GIS à l'Université de Würtzburg, en Allemagne, et est devenu le premier utilisateur en Turquie et les a utilisés dans sa thèse de spécialisation.

Il est devenu spécialiste en chirurgie générale à l'hôpital de formation SSK Okmeydanı en 1996. La même année, IU a suivi les «cours de formation en endoscopie de gastroentérologie chirurgicale» à la faculté de médecine d'Istanbul. En raison de son intérêt pour la chirurgie du foie et des voies biliaires, il est diplômé de l'Université d'Istanbul pendant 4 mois en 1999. Il a travaillé activement dans le département de chirurgie générale du foie et des voies biliaires. Durant cette période, il poursuit des études cliniques et expérimentales.

Areas of Interests

• All skin, hair and nail diseases
• Aesthetic and cosmetic dermatological applications
• Dogol botox (wrinkle treatment, player botox)
• Sweating Botox
• Filling applications
• Stem cell therapies, exosome therapy
• Mesotherapy (hair and face mesotherapy, Paris glow)
• PRP
• Spot treatments
• Laser treatment applications
• Non-surgical skin rejuvenation
• Youth vaccinations
• Acne and acne scar treatment
• Eczema, seborrhoeic dermatitis, urticaria, allergic skin diseases, rosacea, psoriasis
• HPV, sexually transmitted diseases
• Cryotherapy, electrocauterisation, applications
• Nevus (mole) examination, follow-up and surgical mole removal
• Dermatological surgical procedures

Education:

• Mersin Hacı Sabancı Anatolian High School
• Mersin University Faculty of Medicine
• Çukurova University Department of Dermatological and Venereal Diseases

Experience:

• Liv Hospital Ulus

Areas of Interests

• Infertility
• In Vitro Fertilization (IVF) Treatment
• Endometriosis
• Urogynecology (urinary incontinence and uterine prolapse surgeries)
• Gynecological Laparoscopic surgeries
• Hysteroscopic surgeries
• Pregnancy Monitoring
• Myoma surgery
• Ovarian cysts and surgeries
• Gynecological plastic surgeries

Education:

• Ataturk University Faculty of Medicine - Undergraduate
• Abant Izzet Baysal University Faculty of Medicine Gynecology and Obstetrics - Specialization
• Bezmialem Vakif University Faculty of Medicine Istanbul - Assistant Professorship
• Bezmialem Vakif University Faculty of Medicine Istanbul - Associate Professorship
• American Hospital - Assisted Reproductive Specialist Training

Experience:

• Bolu Izzet Baysal State Hospital (Compulsory Service) -Bolu
• Bezmialem Vakif University Faculty of Medicine - Istanbul

Domaines d'intérêt

• Chirurgie reconstructive urogénitale pédiatrique
• Hypospadias
• Circumcision
• Chirurgie oncologique
• Anomalies congénitales du système urinaire supérieur et inférieur
• Chirurgie du nouveau-né
• Chirurgie abdominale pédiatrique

Formation
 

• 1997 - Université 19 Mayıs
• 1998 - Congrès national de chirurgie pédiatrique, Meilleure étude de recherche
• 2001 - Université Kocaeli
• 2007 - Gouvernement du Kosovo
• 2009 - Université Yeditepe
• 2009 - Congrès d'Arabie Saoudite, Meilleure étude clinique

Expérience
 

• Lycée FMV Işık
• Faculté de médecine de l’Université d’Istanbul Cerrahpaşa
• Université Ondokuz Mayıs
• Hôpital pour enfants Zeynep Kamil
• Faculté de médecine de l’Université Kocaeli
• UT Southwestern Medical Center, urologie pédiatrique, Dallas, USA
• Centre médical de l’Université Ege, urologie pédiatrique
• Université Yeditepe

Le Prof. Dr. Selami Sozubir est l’auteur de 65 publications scientifiques, ayant reçu plus de 11 000 lectures et près de 1 000 citations, ce qui témoigne de sa contribution importante dans le domaine de la chirurgie et de l’urologie pédiatriques.

Areas of Interests

• Neuro-oncological surgery
• Spinal Surgery
• Pediatric Neurosurgery
• Peripheral Nerve Surgery
• Functional Neurosurgery and Algology

Education:

• Istanbul University, Faculty of Medicine
• Istanbul Okmeydani Training and Research Hospital

Experience:

• Liv Hospital Ulus
• Sisli Kolan Hospital
• Prof.Dr.Cemil Taşcıoğlu City Hospital
• Ardahan State Hospital

Research:

• Tumor markers and other laboratory findings in brain tumors
• Antiepileptic drugs in operated brain tumors
• Cervical corpectomy techniques
• Pre-emptive analgesia in spine surgeries

Publications:

• Uysal E, Cine HS, Yavuz AY, Cal MA. Impact of subventricular zone interaction on clinical outcomes in patients with intracerebral hematoma. Experimental Biomedical Research, 2024;7(3): 117–126. https://doi.org/10.30714/j-ebr.2024.215
• Çal MA, Yangı K. A Single-center Study Comparing Volumetric and Morphometric Measurements of Chiari Malformation in the Turkish Population. Eur Arc Med Res.2024 Mar;40(1):50-56. doi:10.4274/eamr.galenos.2024.24892.
• Avcı İ, Başkurt O, Şeker S, Kurtuluş Y, Çal MA. Rapid Recurrence of Glioblastoma After 12 Days Despite Gross Total Resection. Eur Arc Med Res.2024 Mar;40(1):62-65. doi:10.4274/eamr.galenos.2024.48615.
• Play MA. The relationship between vertebral compression rates and systemic inflammatory scores in osteoporotic vertebral fractures. Eur Rev Med Pharmacol Sci. 2024;28(3):959-968. doi:10.26355/eurrev_202402_35333
• Çal MA, Gök H. Retrospective Evaluation of the Effect of Surgery and CyberKnife on Recurrence and Neurological Deficits in Cases Diagnosed as Vestibular Schwannoma. Haydarpasa Numune Med J.2023;63 (1), 62 ‑67.doi:10.14744/hnhj.2022.45712
• Uysal E, Çal MA, Cine HS. The use of vancomycin powder in the compound depressed skull fractures. Clin Neurol Neurosurg. 2023;225:107570. doi:10.1016/j.clineuro.2022.107570
• Gök H, Şeker S, Peker HO, Çal MA, Altay T, Çelik S. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. Ulus Travma Emergency Surgery Journal . 2020;26(2):328 ‑330. doi:10.14744/tjtes.2019.02828
• Çınar N,Karaoğlan A,Midi A,Çal MA,Kelten B,Çakmak MA,Şahin Ş. Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol. J. Exp. Clin. Med ., 2014; 31:71 ‑75. doi : 10.5835/jecm.omu.31.02.002
• Karaoglan A, Cal MA, Orki A, Arpaozu BM, Colak A. Pneumorrhachis associated with bronchial asthma , subcutaneous emphysema and pneumomediastinum . Turkish Neurosurg . 2011;21(4):666 ‑668.
• Kelten B, Karaoğlan A, Cal MA, Akdemir O, Karancı T. Human immunodeficiency Bilateral epidural puncture in a patient infected with the virus Hematoma : Case report [ Bilateral epidural hematoma in a patient with Human immunodeficiency virus infection : a case report ]. Ulus Trauma Emergency Surgery Journal . 2013;19(3):267 ‑270. doi: 10.5505 /tjtes.2013.49799
• Karaoglan A, Akdemir O, Cinar N, et al. Correlation between leptin and pro- ‑inflammatory cytokines in cortical contusion injury model. Ulus Trauma Emergency Surgery Journal . 2011;17(4):298 ‑302. doi: 10.5505 /tjtes.2011.69077
• Cal MA, Kelten B, Akbas A, Akdemir O, Karaoglan A. Coexistence of spinal lipoma, ependymal cyst and dermoid cyst in neighboring localizations in context medullaris : A case report . HealthMed . 2013; 7(12):3227
• Canpolat A, Duman H, Akbaş A, Çal MA, Akdemir AO. Diffuse dysphagia and myeloradiculopathy presenting idiopathic skeletal hyperosteosis ( Forestier Disease). TC Maltepe University Medical Faculty Journal.2012;4(2),14 ‑17
• Karaoglan A, Kelten B,Akdemir AO,Çal MA. Lumbar spine presenting with radiculopathy spinal Chondroma : Case report. TC Maltepe University Medical Faculty Journal. 2011;3(3),28 ‑30
•  
• Istanbul Medical Chamber
• Turkish Neurosurgery Association
   

Areas of Interests

• General Urology
• Andrology
• Functional Urology

Education

• Selim Sırrı Tarcan Primary School
• Sisli Terakki High School
• 19 Mayıs University Faculty of Medicine / Urology

Experience

• Liv Hospital Vadistanbul
• Memorial Şişli Hospital Urology
• Şebinkarahisar State Hospital Chief Physician

Research

• Oxidative with Resistive Index in Varicocele
• Relationship Between Stress Factors

Publications

• Effectiveness of Flexible Uteronoscopy and Laser Lithotripsy for Multiple Unilateral
• Ontrarenal Stones Smaller Than 2 cm

Professor Dr. Cenap Zeybek is a respected Pediatric Cardiologist known for his skill in advanced heart procedures. He became an Associate Professor in 2011. In 2017, he was promoted to Professor. This shows his expertise and leadership in pediatric cardiology. Dr. Zeybek has performed many complex surgeries, such as heart valve replacements, open heart operations, and interventional procedures. His work has helped improve outcomes for children with heart conditions.

He has published many scientific articles and given several presentations. This shows his dedication to improving pediatric heart care. Dr. Zeybek’s qualifications and academic success make him a leading expert in his field.

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Dr. Ahmed Fatih Oguc is a specialist in gynecology and obstetrics. He is known for his skill and dedication to women’s health. He graduated from Trakya University Faculty of Medicine. He completed his specialization at Hacettepe University Faculty of Medicine.

Dr. Oguc has worked at leading healthcare institutions. He is committed to high standards of patient care and has earned strong patient satisfaction. He is a member of the Eskisehir Medical Chamber. This shows his commitment to professional growth and medical excellence.

Dr. Mehmet Yigit is an internal medicine specialist. He focuses on diabetes, metabolic syndrome, thyroid diseases, and hypertension. He also treats gastrointestinal problems such as dyspepsia, gastritis, and irritable bowel syndrome. In addition, he manages spondylitis and connective tissue diseases.

Dr. Yigit graduated from Çukurova University Faculty of Medicine in 2007. He completed his internal medicine training at Adnan Menderes University in 2013. He has worked as Assistant Chief Physician at Liv Hospital Ulus. He has held Medical Director roles at Recordati Rare Diseases and Alexion Pharmaceuticals. He has also held leadership positions at Abbvie and Novo Nordisk Pharmaceuticals. Dr. Yigit has served as an internal medicine physician at Manisa State Hospital. He has contributed to research as an assistant at ADU.

Dr. Kubilay Ukinc is a specialist in endocrinology and metabolic diseases. His clinical interests include diabetes, thyroid disorders, obesity, and hypertension. He also treats adrenal and pituitary diseases, as well as hormone-related disorders in both women and men. Dr. Ukinc has expertise in low blood sugar conditions.

He received his medical training at Hacettepe University and Karadeniz Technical University. He has worked in academic and clinical roles at Karadeniz Technical University, Çanakkale Onsekiz Mart University, and Istanbul Bilim University. Dr. Ukinc has broad experience in internal medicine and endocrinology. He is active in both patient care and medical education.